Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (25)

2024

  1. Insights from the Twittersphere: a cross-sectional study of public perceptions, usage patterns, and geographical differences of tweets discussing cocaine

    Frontiers in Psychiatry, Vol. 15

2023

  1. Using Twitter Data Analysis to Understand the Perceptions, Beliefs, and Attitudes about Pharmacotherapy Used in Rheumatology: An Observational Study

    Healthcare (Switzerland), Vol. 11, Núm. 11

2022

  1. Towards the Search for Potential Biomarkers in Osteosarcoma: State-of-the-Art and Translational Expectations

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

2021

  1. Analysis of tweets containing information related to rheumatological diseases on twitter

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 17

  2. Systemic inflammation and the breakdown of intestinal homeostasis are key events in chronic spinal cord injury patients

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-22

2017

  1. The role of IFN-β during the course of sepsis progression and its therapeutic potential

    Frontiers in Immunology

2009

  1. IFNβ therapy progressively normalizes the increased ex vivo T lymphocyte apoptosis observed in active patients with multiple sclerosis

    Clinical Immunology, Vol. 132, Núm. 2, pp. 195-202

2006

  1. XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancer

    British Journal of Cancer, Vol. 94, Núm. 7, pp. 969-975

2004

  1. APRIL promotes B-1 cell-associated neoplasm

    Cancer Cell, Vol. 6, Núm. 4, pp. 399-408

2002

  1. Newborn patients exhibit an unusual pattern of interleukin 10 and interferon γ serum levels in response to cardiac surgery

    Journal of Thoracic and Cardiovascular Surgery, Vol. 123, Núm. 3, pp. 451-458

1999

  1. Granulocyte colony-stimulating factor (G-CSF) transiently suppresses mitogen-stimulated T-cell proliferative response

    British Journal of Cancer, Vol. 80, Núm. 1-2, pp. 229-235

1997

  1. An extract of the fern Polypodium leucotomos inhibits human peripheral blood mononuclear cells proliferation in vitro

    International Journal of Immunopharmacology, Vol. 19, Núm. 1, pp. 9-14

1995

  1. Functional defect of T cells in autoimmune gastritis

    Gut, Vol. 36, Núm. 2, pp. 171-175

  2. Natural killer cell activity in patients with pernicious anemia

    Digestive Diseases and Sciences, Vol. 40, Núm. 7, pp. 1538-1541

1994

  1. Deficient interleukin 2 dependent proliferation pathway in T lymphocytes from active and inactive ulcerative colitis patients

    Gut, Vol. 35, Núm. 7, pp. 955-960

1993

  1. Heterogeneous proliferative effect of tumor necrosis factor‐α and lymphotoxin on mitogen‐activated B cells from B‐chronic lymphocytic leukemia

    American Journal of Hematology, Vol. 43, Núm. 2, pp. 81-85

1992

  1. Deficient interleukin‐2 responsiveness of T lymphocytes from patients with primary biliary cirrhosis

    Hepatology, Vol. 16, Núm. 4, pp. 931-936

  2. Increased spontaneous and lymphokine‐conditioned IgA and IgG synthesis by B cells from alcoholic cirrhotic patients

    Hepatology, Vol. 16, Núm. 3, pp. 664-670

  3. Interleukin 2 and interferon alpha modulation of the lymphocyte non-major histocompatibility-restricted lytic activity in glioblastoma patients

    International Journal of Immunopharmacology, Vol. 14, Núm. 8, pp. 1307-1313

1991

  1. Modulation by interferon alpha of the decreased natural killer activity in patients with glioblastoma

    Acta Neurochirurgica, Vol. 109, Núm. 3-4, pp. 109-113